1,260 results on '"Olivotto, Iacopo"'
Search Results
2. Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis
3. Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal
4. Electrocardiographic abnormalities in patients with cardiomyopathies
5. Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry
6. Atypical Subendocardial Late Gadolinium Enhancement in Anderson-Fabry Cardiomyopathy
7. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
8. Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
9. Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
10. Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
11. Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
12. Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies
13. Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis
14. Inflammation across the spectrum of hypertrophic cardiac phenotypes
15. Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy
16. MYBPC3-c.772G>A mutation results in haploinsufficiency and altered myosin cycling kinetics in a patient induced stem cell derived cardiomyocyte model of hypertrophic cardiomyopathy
17. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
18. Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis
19. From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy
20. Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis
21. Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes
22. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study
23. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
24. Correction to: Clinical staging of Anderson‑Fabry cardiomyopathy: an operative proposal
25. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers
26. Long-Term Effects of Mavacamten on Electromechanical Dispersion and Deformation in Obstructive Hypertrophic Cardiomyopathy
27. Cancer Treatment–Related Complications in Patients With Hypertrophic Cardiomyopathy
28. Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
29. Applications of Gene Therapy in Cardiomyopathies
30. The ventilatory efficiency parameters outperform peak oxygen consumption in monitoring the therapy effects in patients with hypertrophic cardiomyopathy
31. Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort
32. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy
33. Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design
34. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy
35. Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama
36. Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis
37. The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy: Novel ECG Signs
38. Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis
39. International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review
40. The evolving paradigm and current perception of hypertrophic cardiomyopathy: Implications for management
41. Pulmonary congestion during Exercise stress Echocardiography in Hypertrophic Cardiomyopathy
42. Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring
43. Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades
44. Histopathology of the Mitral Valve Residual Leaflet in Obstructive Hypertrophic Cardiomyopathy
45. Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis
46. Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation
47. Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies
48. Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test—echocardiographic study
49. Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era
50. Creatine deficiency and heart failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.